JESÚS FERNANDO
SAN MIGUEL IZQUIERDO
Ikertzailea 1986-2013 tartean
Princess Margaret Cancer Centre
Toronto, CanadáPrincess Margaret Cancer Centre-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2019
2018
2017
-
Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth
British Journal of Haematology, Vol. 178, Núm. 6, pp. 896-905
2015
-
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma
New England Journal of Medicine, Vol. 372, Núm. 2, pp. 142-152
-
Elotuzumab therapy for relapsed or refractory multiple myeloma
New England Journal of Medicine, Vol. 373, Núm. 7, pp. 621-631